Abstract
Objectives: The aim of this study was to describe the profile of patients with cancer pain using oral opioids, to evaluate the therapeutic adherence of these patients and to identify the factors associated with it. Methods: It was a cross-sectional study carried out at the Pharmacy of the Hospital de Câncer de Pernambuco, from March to September 2019. Each patient were selected for convenience and were interviewed once, and the Medicines Evaluation Questionnaire (BMQ) was used to determine adherence and FACS for determine the socioeconomic, demographic and clinical profile. The data was analyzed using the Statistical Package for Social Sciences (SPSS) program. Results: In total, 46 patients were interviewed, aged between 19 and 82 years, 59% did not have complete elementary school, 74% had family income equal or less than 1 minimum wage and 71% classified as non-adherent, with the domain “recall screen” the most scored (84%). Patients using controlled-release medications (p = 0.0000352) and with higher levels of education (p = 0.016) obtain better adherence results in the BMQ questionnaire. Conclusions: Through the study it was possible to identify a high incidence of patients not adhering to drug therapy and their socioeconomic profile, highlighting the need for political and institutional interventions. Due to the scarcity of publications, further studies are needed to determine adherence factors in patients with cancer pain.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.